MR-proAdrenomedullin as a predictor of renal replacement therapy in a cohort of critically ill patients with COVID-19.
Kevin RoedlDominik JarczakMarlene FischerMunif HaddadOlaf BoenischGeraldine de HeerChristoph BurdelskiDaniel FringsBarbara SensenMahir KarakasStefan KlugeAxel NierhausPublished in: Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals (2021)
AKI requiring RRT is frequent in ICU patients with COVID-19. MR-proADM on admission was able to predict RRT requirement, which may be of interest for risk stratification and management.